OCR Output

REFERENCES = 101

Meshack, A., Peters, R. ]., Jr., Lin, M.-T., Hill, M., Abughosh, S., & Essien, E. J. (2013).
The beliefs of teenage male cannabinoid users: a qualitative study. American Jour¬
nal of Health Studies, 28(3), 109-113.

Miller, G. D., & Baldwin, J. D. C. (1987). Implications of the wounded-healer para¬
digm for the use of the self in therapy. Journal of Psychotherapy & the Family, 3(1),
139-151.

Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2012). Time changes
everything? A qualitative investigation of the experience of auditory verbal hal¬
lucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438

Milligan, D., McCarthy-Jones, S., Winthrop, A., & Dudley, R. (2013). Time changes
everything? A qualitative investigation of the experience of auditory verbal hal¬
lucinations over time. Psychosis, 5(2), 107-118. doi: 10.1080/17522439.2012.667438

Moré, L., & Racz, J. (2013). Online drug user-led harm reduction in Hungary: a review
of “Daath”. Harm Reduction Journal, 10(1), 18.

Miiller, Kornhuber, J., & Sperling, W. (2015). The behavioral profile of spice and
synthetic cannabinoids in humans. Brain Research Bulletin. doi: 10.1016/j.brain¬
resbull.2015.10.013

Müller, Sperling, W., Köhrmann, M., Huttner, B. H., Kornhuber, ]J., & Maler, J. M. (2010).
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis
induced recurrent psychotic episodes. Schizophrenia Research, 118, 309-310.

Nacca, N., Vatti, D., Sullivan, R., Sud, P, Su, M., & Marraffa, J. (2013). The synthetic
cannabinoid withdrawal syndrome. Journal of Addiction Medicine, 7(4), 296-298.
doi: 10.1097/ADM.0b013e31828e1881

Nagy, Z. (2015). “..életiink minden megnyilvanuldsdban.” A felépiilés életrendje és
értékrendje 12 lépéses programokban józanodó szerfüggők körében. Eötvös Lóránd
University, Budapest.

Nakajima, J. i., Takahashi, M., Seto, T., Kanai, C., Suzuki, J., Yoshida, M.,... Hamano,
T. (2013). Analysis of azepane isomers of AM-2233 and AM-1220, and detection
of an inhibitor of fatty acid amide hydrolase [3’-(aminocarbonyl)(1, 1'-biphenyl)¬
3-yl]-cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo
area. Forensic Toxicology, 31(1), 76-85.

National Institute of Mental Health. Questions and answears about psychosis. Re¬
trieved 26-01-2019, from https://www.nimh.nih.gov/health/topics/schizophrenia/
raise/raise-questions-and-answers.shtml#1

Newton, E., Larkin, M., Melhuish, R., & Wykes, T. (2007). More than just a place to
talk: Young people’s experiences of group psychological therapy as an early inter¬
vention for auditory hallucinations. Psychology and Psychotherapy: Theory, Re¬
search and Practice, 80(1), 127-149. doi: 10.1348/147608306X110148

Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso Mateos, J. L. (2012).
The continuum of psychotic symptoms in the general population: a cross-national
study. Schizophrenia Bulletin, 38(475-485). doi: doi: 10.1093/schbul/sbq099